Logo image of NIR

NEAR INTELLIGENCE INC (NIR) Stock Fundamental Analysis

NASDAQ:NIR - Nasdaq - US6394941032 - Common Stock - Currency: USD

0.033  -0.03 (-44.07%)

After market: 0.0289 0 (-12.42%)

Fundamental Rating

1

Overall NIR gets a fundamental rating of 1 out of 10. We evaluated NIR against 282 industry peers in the Software industry. NIR has a bad profitability rating. Also its financial health evaluation is rather negative. NIR is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

NIR had negative earnings in the past year.
NIR Yearly Net Income VS EBIT VS OCF VS FCFNIR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 -20M -40M -60M -80M -100M

1.2 Ratios

NIR has a worse Return On Assets (-41.37%) than 79.72% of its industry peers.
NIR has a worse Return On Equity (-1715.13%) than 90.04% of its industry peers.
Industry RankSector Rank
ROA -41.37%
ROE -1715.13%
ROIC N/A
ROA(3y)-52.49%
ROA(5y)N/A
ROE(3y)-161.97%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NIR Yearly ROA, ROE, ROICNIR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 -50 -100 -150 -200 -250

1.3 Margins

NIR has a worse Gross Margin (25.57%) than 82.21% of its industry peers.
The Profit Margin and Operating Margin are not available for NIR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 25.57%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NIR Yearly Profit, Operating, Gross MarginsNIR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 0 -100 -200 -300

More info and screens

1

2. Health

2.1 Basic Checks

NIR does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, NIR has about the same amount of shares outstanding.
NIR has a worse debt/assets ratio than last year.
NIR Yearly Shares OutstandingNIR Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 10M 20M 30M 40M
NIR Yearly Total Debt VS Total AssetsNIR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 50M 100M 150M

2.2 Solvency

Based on the Altman-Z score of -3.67, we must say that NIR is in the distress zone and has some risk of bankruptcy.
NIR has a worse Altman-Z score (-3.67) than 85.41% of its industry peers.
A Debt/Equity ratio of 0.18 indicates that NIR is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.18, NIR is in line with its industry, outperforming 47.33% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF N/A
Altman-Z -3.67
ROIC/WACCN/A
WACC4.3%
NIR Yearly LT Debt VS Equity VS FCFNIR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 0 20M -20M 40M 60M 80M

2.3 Liquidity

A Current Ratio of 0.56 indicates that NIR may have some problems paying its short term obligations.
The Current ratio of NIR (0.56) is worse than 91.46% of its industry peers.
NIR has a Quick Ratio of 0.56. This is a bad value and indicates that NIR is not financially healthy enough and could expect problems in meeting its short term obligations.
NIR has a Quick ratio of 0.56. This is amonst the worse of the industry: NIR underperforms 91.10% of its industry peers.
Industry RankSector Rank
Current Ratio 0.56
Quick Ratio 0.56
NIR Yearly Current Assets VS Current LiabilitesNIR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 20M 40M 60M 80M

More info and screens

4

3. Growth

3.1 Past

The earnings per share for NIR have decreased strongly by -204.05% in the last year.
NIR shows a strong growth in Revenue. In the last year, the Revenue has grown by 31.84%.
EPS 1Y (TTM)-204.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)31.84%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

NIR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 27.22% yearly.
The Revenue is expected to grow by 27.62% on average over the next years. This is a very strong growth
EPS Next Y26.38%
EPS Next 2Y27.22%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year27.15%
Revenue Next 2Y27.62%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

NIR Yearly Revenue VS EstimatesNIR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 20M 40M 60M 80M
NIR Yearly EPS VS EstimatesNIR Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 -0.5 -1 -1.5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NIR. In the last year negative earnings were reported.
Also next year NIR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NIR Price Earnings VS Forward Price EarningsNIR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NIR Per share dataNIR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 -1

4.3 Compensation for Growth

NIR's earnings are expected to grow with 27.22% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y27.22%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for NIR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NEAR INTELLIGENCE INC

NASDAQ:NIR (12/18/2023, 8:15:10 PM)

After market: 0.0289 0 (-12.42%)

0.033

-0.03 (-44.07%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-14 2023-11-14/amc
Earnings (Next)03-26 2024-03-26/amc
Inst Owners5.01%
Inst Owner Change0%
Ins Owners33.62%
Ins Owner Change0%
Market Cap1.67M
Analysts80
Price Target3.57 (10718.18%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-22.22%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-8.2%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.09%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.03
P/FCF N/A
P/OCF N/A
P/B 0.43
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.42
EYN/A
EPS(NY)-0.86
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS1.27
BVpS0.08
TBVpS-1.3
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -41.37%
ROE -1715.13%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 25.57%
FCFM N/A
ROA(3y)-52.49%
ROA(5y)N/A
ROE(3y)-161.97%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.56
Quick Ratio 0.56
Altman-Z -3.67
F-ScoreN/A
WACC4.3%
ROIC/WACCN/A
Cap/Depr(3y)2095.66%
Cap/Depr(5y)N/A
Cap/Sales(3y)18.77%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-204.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y26.38%
EPS Next 2Y27.22%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)31.84%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year27.15%
Revenue Next 2Y27.62%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-428.05%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year63.63%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-27.31%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-23.8%
OCF growth 3YN/A
OCF growth 5YN/A